Children with cystic fibrosis in South Africa: an improving nutritional picture

A T Westwood1, J D Ireland

  • 1Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa. Westwood@ich.uct.ac.za

Insights

Improved growth in South African children with cystic fibrosis (CF) was observed between 1986 and 1996. This nutritional status enhancement in young CF patients suggests a better long-term prognosis in resource-limited settings.

Area of Science:

  • Pediatric Nutrition
  • Genetic Disorders
  • Public Health

Background:

  • Nutritional status and growth are critical determinants of prognosis in cystic fibrosis (CF).
  • South African CF patients have a median survival of 18 years, highlighting the need for improved management.
  • Understanding growth patterns is essential for enhancing patient outcomes in CF.

Purpose of the Study:

  • To analyze the longitudinal growth patterns of a South African cystic fibrosis (CF) population.
  • To assess changes in nutritional status indicators over a decade (1986-1996).
  • To evaluate the impact of interventions on growth in a resource-limited setting for CF patients.

Main Methods:

  • Retrospective chart review of CF patients in South Africa.
  • Calculation of weight-for-age, height-for-age, and weight-for-height indices for 1986 and 1996.
  • Statistical comparison of growth indices between the two study periods.

Main Results:

  • Mean nutritional indices remained consistent between 1986 and 1996 for the overall CF population.
  • Children aged 5-10 years showed a significant improvement in mean weight-for-age in 1996 (94.2%) compared to 1986.
  • This improvement represented a 14.3% increase, indicating enhanced growth in younger CF patients.

Conclusions:

  • Significant improvements in the growth of young children with cystic fibrosis have been achieved in South Africa.
  • These findings suggest that enhanced nutritional status can positively influence the prognosis of CF patients.
  • The study demonstrates the feasibility of improving CF patient outcomes even in resource-poor environments.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...